Results 231 to 240 of about 518,198 (339)
Improving selectivity within therapeutic design is critical to ensure targeted delivery to brain tumors. Targeting the cellular membrane composition distinctive of the blood–brain barrier and brain cancer cells is explored in this review. Nanomedicine can be utilized for precise tumor recognition, and detailed mechanistic interactions of therapeutics ...
Mahnoor Kadri +2 more
wiley +1 more source
Clinical significance of cyclin-dependent kinase inhibitor 3 in hepatocellular carcinoma. [PDF]
Liu X, Chang K, Liu J.
europepmc +1 more source
ABSTRACT Objective Aging alters mesenchymal stromal cell (MSC) function, leading to dysregulated adipogenesis across tissues through biased lineage commitment. Fat redistribution from adipose depots to skeletal muscle and bone marrow is common in aging, but the underlying mechanisms remain unclear.
Xu Zhang +13 more
wiley +1 more source
Efficacy and Predictability of Cyclin-Dependent Kinase 4/6 Inhibitors in HER2-Positive Breast Cancer. [PDF]
Abbasi MS +3 more
europepmc +1 more source
Cyclin-dependent kinase 5-mediated phosphorylation of chloride intracellular channel 4 promotes oxidative stress-induced neuronal death [PDF]
Dong Guo +11 more
openalex +1 more source
Exploration of Therapeutic Targets Using CDK4 Inhibitors for Head and Neck Mucosal Melanoma
Abstract Objective Mucosal melanoma (MM) is an extremely aggressive malignant tumor in the head and neck region associated with a poor prognosis. In the present study, we conducted cell proliferation assay and western blotting using cell lines derived from MM and the immunohistochemical analysis of pathological MM tissues to identify novel therapeutic ...
Takayoshi Hattori +14 more
wiley +1 more source
PAK4 phosphorylates cyclin-dependent kinase 2 to promote the G<sub>1</sub>/S transition during adipogenesis. [PDF]
Yu HC +9 more
europepmc +1 more source
Activation of the
Xiaolong Liu +6 more
openalex +1 more source

